Event: Kindred Biosciences Announces Positive Results from Pilot Effectiveness Study of its Fully Caninized IL-31 Antibody for the Treatment of Atopic Dermatitis in Dogs and Issuance of U.S. Patent

Tuesday, October 30, 2018

Time of Event: 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time

Telephone Dial in: toll-free (855) 433-0927 from the US, or (484) 756-4262 internationally

Conference ID:7047158

For more information about this event, please see the press release.